Pub Date : 2025-09-30eCollection Date: 2025-01-01DOI: 10.1155/jotm/5405719
Elif Nur Yildirim-Ozturk
Background: Mosquito-borne diseases are a major cause of mortality and disease burden worldwide. This study aimed to assess the trends in total disability-adjusted life years (DALYs) due to five mosquito-borne diseases, as well as their association with poverty, gender inequality, underdevelopment, globalization, and climate change, both globally and for the period from 1990 to 2021.
Methods: This ecological time-series study with a longitudinal analytical framework used a total of 27 variables obtained from different sources. The dependent variable of the study was mosquito-borne DALYs. The trend of the numerical variables over time was analyzed using joinpoint regression. The relationships between the dependent variable and the independent variables were examined using univariate linear regression, LASSO regression, and ridge regression. p < 0.05 was considered statistically significant.
Results: During the study period, mosquito-borne DALYs decreased by 1.13 per 100,000 persons per year. The LASSO regression model explained 97.9% of the variability in mosquito-borne DALYs. Poverty headcount ratio at $6.85 a day, share of seats in parliament (female), global greenhouse gas emission, and Gender Inequality Index were found to be the most influential variables on mosquito-borne DALYs, respectively. When the optimum lambda, R2, MSE, and RMSE values were analyzed, the LASSO regression model was found to be more compatible than ridge regression for this data set.
Conclusion: The results demonstrate that mosquito-borne DALYs are primarily driven by poverty but are also influenced by gender inequality and climate change. These results highlight the urgent need for integrated and multifaceted public health strategies that go beyond traditional vector control methods.
{"title":"What Could Be Responsible for Some Mosquito-Borne Diseases? Is It Poverty, Gender Inequality, Underdevelopment, Globalization, or Climate Change? Which One(s)?","authors":"Elif Nur Yildirim-Ozturk","doi":"10.1155/jotm/5405719","DOIUrl":"10.1155/jotm/5405719","url":null,"abstract":"<p><strong>Background: </strong>Mosquito-borne diseases are a major cause of mortality and disease burden worldwide. This study aimed to assess the trends in total disability-adjusted life years (DALYs) due to five mosquito-borne diseases, as well as their association with poverty, gender inequality, underdevelopment, globalization, and climate change, both globally and for the period from 1990 to 2021.</p><p><strong>Methods: </strong>This ecological time-series study with a longitudinal analytical framework used a total of 27 variables obtained from different sources. The dependent variable of the study was mosquito-borne DALYs. The trend of the numerical variables over time was analyzed using joinpoint regression. The relationships between the dependent variable and the independent variables were examined using univariate linear regression, LASSO regression, and ridge regression. <i>p</i> < 0.05 was considered statistically significant.</p><p><strong>Results: </strong>During the study period, mosquito-borne DALYs decreased by 1.13 per 100,000 persons per year. The LASSO regression model explained 97.9% of the variability in mosquito-borne DALYs. Poverty headcount ratio at $6.85 a day, share of seats in parliament (female), global greenhouse gas emission, and Gender Inequality Index were found to be the most influential variables on mosquito-borne DALYs, respectively. When the optimum lambda, <i>R</i> <sup>2</sup>, MSE, and RMSE values were analyzed, the LASSO regression model was found to be more compatible than ridge regression for this data set.</p><p><strong>Conclusion: </strong>The results demonstrate that mosquito-borne DALYs are primarily driven by poverty but are also influenced by gender inequality and climate change. These results highlight the urgent need for integrated and multifaceted public health strategies that go beyond traditional vector control methods.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"5405719"},"PeriodicalIF":2.5,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549193/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145372819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-29eCollection Date: 2025-01-01DOI: 10.1155/jotm/7530351
Charles D Kato, Angella Musewa, Tequiero A Okumu, Margaret Mbuchi, Edwinah Atusingwize, Ivan Ankunda, Santiago C Tomas, Gloria Pol Ferrer, Benard Matovu, Emmanuel Muhumuza, Marta Planellas Bachs, Jesus Muro Figueres, James Robert Ochieng
To date, the reservoir host for visceral leishmaniasis, a neglected tropical disease caused by Leishmania donovani, is unknown, although studies pointing to dogs, domestic animals, and rodents are emerging. We aimed to investigate whether the dog (Canis familiaris, Linnaeus, 1758) is a potential reservoir for L. donovani in the Karamoja subregion of Uganda. Blood and lymph node aspirates were purposively collected from dogs (n = 139) in disease endemic villages of Amudat and Moroto districts in August 2023. An indirect enzyme-linked immunosorbent assay was used to detect anti-Leishmania IgG antibodies in serum. DNA extracted from lymph node aspirates was subjected to a polymerase chain reaction (PCR) targeting the rRNA internal transcribed spacer region of Leishmania species. The sera from 139 dogs did not demonstrate any evidence of circulating antibodies against Leishmania, as the optical density (OD) values were all below 0.25, lower than the threshold value of 0.45. Similarly, all the dog lymph node DNAs (n = 139) were negative for Leishmania parasites. Although our results found no evidence to support dogs as reservoirs for L. donovani, in this study, further research utilizing larger sample sizes is recommended to confirm this finding. Furthermore, the presence of L. donovani in sand flies and other suspected reservoirs, such as domestic animals and wild rodents, requires further investigation.
{"title":"Detection of <i>Leishmania donovani</i> Status in Dogs (<i>Canis familiaris,</i> Linnaeus, 1758) in the Karamoja Subregion of Uganda.","authors":"Charles D Kato, Angella Musewa, Tequiero A Okumu, Margaret Mbuchi, Edwinah Atusingwize, Ivan Ankunda, Santiago C Tomas, Gloria Pol Ferrer, Benard Matovu, Emmanuel Muhumuza, Marta Planellas Bachs, Jesus Muro Figueres, James Robert Ochieng","doi":"10.1155/jotm/7530351","DOIUrl":"10.1155/jotm/7530351","url":null,"abstract":"<p><p>To date, the reservoir host for visceral leishmaniasis, a neglected tropical disease caused by <i>Leishmania donovani</i>, is unknown, although studies pointing to dogs, domestic animals, and rodents are emerging. We aimed to investigate whether the dog (<i>Canis familiaris</i>, Linnaeus, 1758) is a potential reservoir for <i>L</i>. <i>donovan</i>i in the Karamoja subregion of Uganda. Blood and lymph node aspirates were purposively collected from dogs (<i>n</i> = 139) in disease endemic villages of Amudat and Moroto districts in August 2023. An indirect enzyme-linked immunosorbent assay was used to detect anti-<i>Leishmania</i> IgG antibodies in serum. DNA extracted from lymph node aspirates was subjected to a polymerase chain reaction (PCR) targeting the rRNA internal transcribed spacer region of <i>Leishmania</i> species. The sera from 139 dogs did not demonstrate any evidence of circulating antibodies against <i>Leishmania</i>, as the optical density (OD) values were all below 0.25, lower than the threshold value of 0.45. Similarly, all the dog lymph node DNAs (<i>n</i> = 139) were negative for <i>Leishmania</i> parasites. Although our results found no evidence to support dogs as reservoirs for <i>L</i>. <i>donovani</i>, in this study, further research utilizing larger sample sizes is recommended to confirm this finding. Furthermore, the presence of <i>L</i>. <i>donovani</i> in sand flies and other suspected reservoirs, such as domestic animals and wild rodents, requires further investigation.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"7530351"},"PeriodicalIF":2.5,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500372/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145244858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-22eCollection Date: 2025-01-01DOI: 10.1155/jotm/4939367
Babayemi O Olakunde, Daniel A Adeyinka, Olubunmi A Olakunde, Stanley C Eneh, Temitayo Ogundipe
Background: Nigeria has the highest burden of hepatitis B virus (HBV) infection in sub-Saharan Africa. However, the lack of a robust surveillance system and program data has limited the understanding of the burden and the distribution of HBV across different populations. This narrative review aimed to summarize available data on the epidemiology of HBV in Nigeria and identify research gaps in the existing literature. Methods: We searched PubMed, Scopus, and Google Scholar for relevant articles published between January 2000 and June 2025. Primary studies, reviews, and reports that contained data of interest, including prevalence, incidence, mode of transmission, mortality, and genotypes, were included in this review. Where available, we restricted our results to findings from representative surveys (conducted across the six geopolitical zones) or systematic reviews. Prevalence rates < 2%, 2%-7%, and ≥ 8% were described as low, intermediate, and high, respectively. Results: Studies on the prevalence of hepatitis B surface antigen (HBsAg) have reported intermediate to high rates in the general population (5.4%-13.6%), with evidence suggesting declining trend. The most recent estimates showed a prevalence of 5.4% in 2022, corresponding to approximately 14.4 million people living with HBV. Available data indicate sociodemographic disparities in HBV prevalence, with higher rates among men, adults (> 18 years), and rural dwellers. Reported prevalence rates among specific subpopulations include blood donors (13.2%-14.0%), pregnant women (5.5%-14.1%), prison inmates (4%-42.2%), people who inject drugs (7%-7.8%), healthcare workers (1.1%-25.7%), female sex workers (0%-17.1%), men who have sex with men (8.4%-11.7%), and transgender women (15.6%). The prevalence of hepatitis B e-antigen (HBeAg) in the general population ranged from 6.0% to 23.6%. The prevalence of occult HBV infection (OBI) ranged from 0.9% to 17.0%. Genotype E was consistently reported as the predominant HBV genotype. Most studies reported low, intermediate, and high prevalence rates for HBV-hepatitis C virus (HCV), HBV-hepatitis D virus (HDV), and HBV-HIV coinfections, respectively. In 2022, approximately 46,000 deaths were attributed to HBV, translating to a mortality rate of 21 per 100,000 population. Conclusions: A wide range of HBV prevalence rates has been observed across various population groups in Nigeria. Key research gaps in HBV epidemiology that must be addressed include modes of transmission, incidence rate, prevalence among key populations, prevalence of OBI in the general population, and spatial distribution of the burden.
{"title":"Epidemiology of Hepatitis B Virus Infection in Nigeria: A Narrative Review of Prevalence, Transmission, Genotypes, Coinfections, and Mortality.","authors":"Babayemi O Olakunde, Daniel A Adeyinka, Olubunmi A Olakunde, Stanley C Eneh, Temitayo Ogundipe","doi":"10.1155/jotm/4939367","DOIUrl":"10.1155/jotm/4939367","url":null,"abstract":"<p><p><b>Background:</b> Nigeria has the highest burden of hepatitis B virus (HBV) infection in sub-Saharan Africa. However, the lack of a robust surveillance system and program data has limited the understanding of the burden and the distribution of HBV across different populations. This narrative review aimed to summarize available data on the epidemiology of HBV in Nigeria and identify research gaps in the existing literature. <b>Methods:</b> We searched PubMed, Scopus, and Google Scholar for relevant articles published between January 2000 and June 2025. Primary studies, reviews, and reports that contained data of interest, including prevalence, incidence, mode of transmission, mortality, and genotypes, were included in this review. Where available, we restricted our results to findings from representative surveys (conducted across the six geopolitical zones) or systematic reviews. Prevalence rates < 2%, 2%-7%, and ≥ 8% were described as low, intermediate, and high, respectively. <b>Results:</b> Studies on the prevalence of hepatitis B surface antigen (HBsAg) have reported intermediate to high rates in the general population (5.4%-13.6%), with evidence suggesting declining trend. The most recent estimates showed a prevalence of 5.4% in 2022, corresponding to approximately 14.4 million people living with HBV. Available data indicate sociodemographic disparities in HBV prevalence, with higher rates among men, adults (> 18 years), and rural dwellers. Reported prevalence rates among specific subpopulations include blood donors (13.2%-14.0%), pregnant women (5.5%-14.1%), prison inmates (4%-42.2%), people who inject drugs (7%-7.8%), healthcare workers (1.1%-25.7%), female sex workers (0%-17.1%), men who have sex with men (8.4%-11.7%), and transgender women (15.6%). The prevalence of hepatitis B e-antigen (HBeAg) in the general population ranged from 6.0% to 23.6%. The prevalence of occult HBV infection (OBI) ranged from 0.9% to 17.0%. Genotype E was consistently reported as the predominant HBV genotype. Most studies reported low, intermediate, and high prevalence rates for HBV-hepatitis C virus (HCV), HBV-hepatitis D virus (HDV), and HBV-HIV coinfections, respectively. In 2022, approximately 46,000 deaths were attributed to HBV, translating to a mortality rate of 21 per 100,000 population. <b>Conclusions:</b> A wide range of HBV prevalence rates has been observed across various population groups in Nigeria. Key research gaps in HBV epidemiology that must be addressed include modes of transmission, incidence rate, prevalence among key populations, prevalence of OBI in the general population, and spatial distribution of the burden.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"4939367"},"PeriodicalIF":2.5,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145232870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-15eCollection Date: 2025-01-01DOI: 10.1155/jotm/4460220
Getnet Atenafu, Netuhsew Atnaf
Due to the increasing resistance to synthetic insecticides and the proliferation of resistant strains of malaria vectors, plant-derived essential oils (EOs) are gaining prominence as an alternative for controlling Anopheles gambiae s.l. larvae. This study evaluated the larvicidal efficacy of EOs from Azadirachta indica and Schinus molle, both individually and in combination, against early 4th-instar Anopheles gambiae s.l. larvae under laboratory and semifield conditions. The EOs were extracted using ethanol in a Soxhlet apparatus. Twenty-five treatments were arranged in a completely randomized design for experimentation. Temephos (Abate) and distilled water served as positive and negative controls, respectively. Each treatment contained 20 larvae, which were acclimatized for 2 h prior to exposure to EOs. Treatment cups were covered with muslin cloth to prevent debris contamination. Larval mortality was assessed at 24, 48, and 72 h postexposure at concentrations of 25, 50, and 75 ppm. In the laboratory, A. indica oil exhibited the highest larvicidal activity among plant treatments, with 71.66% mortality at 75 ppm after 72 h, while S. molle and the combined treatment produced moderate effects. LC50 and LC90 values confirmed A. indica's superior potency, with significantly lower lethal concentrations across all exposure times (p < 0.05). In simulated field trials, A. indica oil also demonstrated time- and dose-dependent larvicidal activity, achieving 68.33% mortality at 75 ppm after 72 h. Synthetic larvicide Temephos (Abate) consistently caused 100% mortality within 24 h at all concentrations in both settings. These findings suggest that A. indica EO, particularly at higher concentrations and longer exposures, may serve as an effective botanical alternative for larval control in integrated vector management programs.
{"title":"Efficacy of Seed Oils From <i>Azadirachta indica</i> and <i>Schinus molle</i> and Their Combination Against <i>Anopheles gambiae</i> s.l.","authors":"Getnet Atenafu, Netuhsew Atnaf","doi":"10.1155/jotm/4460220","DOIUrl":"10.1155/jotm/4460220","url":null,"abstract":"<p><p>Due to the increasing resistance to synthetic insecticides and the proliferation of resistant strains of malaria vectors, plant-derived essential oils (EOs) are gaining prominence as an alternative for controlling <i>Anopheles gambiae s</i>.<i>l</i>. larvae. This study evaluated the larvicidal efficacy of EOs from <i>Azadirachta indica</i> and <i>Schinus molle</i>, both individually and in combination, against early 4<sup>th</sup>-instar <i>Anopheles gambiae s</i>.<i>l</i>. larvae under laboratory and semifield conditions. The EOs were extracted using ethanol in a Soxhlet apparatus. Twenty-five treatments were arranged in a completely randomized design for experimentation. Temephos (Abate) and distilled water served as positive and negative controls, respectively. Each treatment contained 20 larvae, which were acclimatized for 2 h prior to exposure to EOs. Treatment cups were covered with muslin cloth to prevent debris contamination. Larval mortality was assessed at 24, 48, and 72 h postexposure at concentrations of 25, 50, and 75 ppm. In the laboratory, <i>A. indica</i> oil exhibited the highest larvicidal activity among plant treatments, with 71.66% mortality at 75 ppm after 72 h, while <i>S. molle</i> and the combined treatment produced moderate effects. LC<sub>50</sub> and LC<sub>90</sub> values confirmed <i>A. indica</i>'s superior potency, with significantly lower lethal concentrations across all exposure times (<i>p</i> < 0.05). In simulated field trials, <i>A. indica</i> oil also demonstrated time- and dose-dependent larvicidal activity, achieving 68.33% mortality at 75 ppm after 72 h. Synthetic larvicide Temephos (Abate) consistently caused 100% mortality within 24 h at all concentrations in both settings. These findings suggest that <i>A. indica</i> EO, particularly at higher concentrations and longer exposures, may serve as an effective botanical alternative for larval control in integrated vector management programs.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"4460220"},"PeriodicalIF":2.5,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12453931/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145131131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-11eCollection Date: 2025-01-01DOI: 10.1155/jotm/9827589
[This corrects the article DOI: 10.1155/jotm/5040196.].
[这更正了文章DOI: 10.1155/jotm/5040196.]。
{"title":"Corrigendum to \"Primary and Nested PCR Amplification of B1 Gene to Confirm Seropositivity of Toxoplasmosis Among Cancer Patients in Sri Lanka\".","authors":"","doi":"10.1155/jotm/9827589","DOIUrl":"https://doi.org/10.1155/jotm/9827589","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1155/jotm/5040196.].</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"9827589"},"PeriodicalIF":2.5,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12446584/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145113709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-10eCollection Date: 2025-01-01DOI: 10.1155/jotm/9760139
[This corrects the article DOI: 10.1155/jotm/1307578.].
[这更正了文章DOI: 10.1155/jotm/1307578.]。
{"title":"Corrigendum to \"Protocol for an Exploratory RCT of the Traumatic Stress Relief Intervention With Persons With Lived Experience of Leprosy in Addis Ababa, Ethiopia\".","authors":"","doi":"10.1155/jotm/9760139","DOIUrl":"https://doi.org/10.1155/jotm/9760139","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1155/jotm/1307578.].</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"9760139"},"PeriodicalIF":2.5,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12443501/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145086508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Iran is a significant center for cutaneous leishmaniasis, making it crucial to identify transmission modes and control measures to improve public health. Due to the frequent cases of leishmaniasis at health centers in Neyshabur and Firuzeh, this study aimed to create a comprehensive profile of the demographic and environmental factors influencing the prevalence of this condition. This retrospective study utilized secondary data involving 807 patients with suspected cutaneous leishmaniasis, referred to various health facilities, including clinics, outpatient centers, and hospitals in Neyshabur and Firuzeh Counties between 2013 and 2019. Of the total patients, 47.6% were male and 52.4% were female. The highest disease incidence was observed in middle-aged individuals, with 68% of cases occurring in urban areas and the remainder in rural settings. Of those infected, roughly 55% had no recent travel history, while approximately 45% reported recent travel. Among the subjects studied, 58.73% had one wound, 17.22% had two, and 7.08% had five or more. The hand was the most affected area, representing 20.69% of cases, followed by the face at 19.21%. A statistical correlation was found between patients' place of residence and occupational group with the type of cutaneous leishmaniasis. The incidence of the disease declined in 2018, but Neyshabur's central districts showed a higher average annual incidence rate than other studied areas, indicating increased risk for residents contracting cutaneous leishmaniasis. This highlights the need for targeted education for at-risk populations to reduce incidence rates and prevent disease spread.
{"title":"Investigating the Effects of Demographic Factors on the Prevalence of Cutaneous Leishmaniasis in a Focus Area of Northeastern Iran.","authors":"Fateme Rajabi Gharaii, Mitra Boroomand, Amin Mohammadpour, Mohadeseh Motamed-Jahromi, Aboozar Soltani","doi":"10.1155/jotm/7537793","DOIUrl":"10.1155/jotm/7537793","url":null,"abstract":"<p><p>Iran is a significant center for cutaneous leishmaniasis, making it crucial to identify transmission modes and control measures to improve public health. Due to the frequent cases of leishmaniasis at health centers in Neyshabur and Firuzeh, this study aimed to create a comprehensive profile of the demographic and environmental factors influencing the prevalence of this condition. This retrospective study utilized secondary data involving 807 patients with suspected cutaneous leishmaniasis, referred to various health facilities, including clinics, outpatient centers, and hospitals in Neyshabur and Firuzeh Counties between 2013 and 2019. Of the total patients, 47.6% were male and 52.4% were female. The highest disease incidence was observed in middle-aged individuals, with 68% of cases occurring in urban areas and the remainder in rural settings. Of those infected, roughly 55% had no recent travel history, while approximately 45% reported recent travel. Among the subjects studied, 58.73% had one wound, 17.22% had two, and 7.08% had five or more. The hand was the most affected area, representing 20.69% of cases, followed by the face at 19.21%. A statistical correlation was found between patients' place of residence and occupational group with the type of cutaneous leishmaniasis. The incidence of the disease declined in 2018, but Neyshabur's central districts showed a higher average annual incidence rate than other studied areas, indicating increased risk for residents contracting cutaneous leishmaniasis. This highlights the need for targeted education for at-risk populations to reduce incidence rates and prevent disease spread.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"7537793"},"PeriodicalIF":2.5,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12425619/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145065155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background:Anopheles arabiensis, the primary malaria vector in Ethiopia, exhibits diverse feeding behaviors influenced by geography, climate, and control strategies. Understanding its blood-feeding preference is crucial for devising effective interventions. This study aimed to conduct a systematic review and meta-analysis of existing evidence on An. arabiensis human blood index (HBI) in Ethiopia. Methods: A comprehensive search of multiple electronic databases was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Study quality was assessed using criteria adopted from the Joanna Briggs Institute (JBI) appraisal checklist. Data were analyzed using Stata Version 17, employing a random-effects model to estimate the pooled HBI at 95% confidence interval (CI). Subgroup analysis and meta-regression were performed based on regions and mosquito collection methods. Heterogeneity was assessed using the I2 test. Results: A total of 19 studies published from 1997 to 2023 were included, encompassing 12,794 blood-fed An. arabiensis. The meta-analysis revealed a pooled HBI of 37.18% (95% CI: 21.26-44.28). Subgroup analysis showed regional variation, with the highest HBI reported in Mixed Region 3 (covering Afar, Oromia, and the Amhara Regional States) at 64.02% (95% CI: 61.78-66.25), and the lowest in the Amhara Regional State at 7.53% (95% CI: -1.58-16.65). Temporal analysis indicated fluctuations over time, with the highest HBI reported in 2014 (70.62%, 95% CI: 68.72-72.46) and the lowest in 2021 (0%, 95% CI: 0.00-1.30). Conclusion: The present study found that An. arabiensis in Ethiopia exhibits a moderate preference for human blood, with a pooled HBI of 37.18%. However, significant variation exists across regions and over time. Continuous surveillance and further research are needed to explore the underlying factors influencing HBI and to guide evidence-based malaria prevention and control strategies.
{"title":"Human Blood Index of <i>Anopheles arabiensis</i> in Ethiopia: A Systematic Review and Meta-Analysis.","authors":"Solomon Yeshanew, Fasil Adugna Kendie, Endalkachew Nibret, Getnet Atenafu","doi":"10.1155/jotm/7891775","DOIUrl":"10.1155/jotm/7891775","url":null,"abstract":"<p><p><b>Background:</b> <i>Anopheles arabiensis</i>, the primary malaria vector in Ethiopia, exhibits diverse feeding behaviors influenced by geography, climate, and control strategies. Understanding its blood-feeding preference is crucial for devising effective interventions. This study aimed to conduct a systematic review and meta-analysis of existing evidence on <i>An. arabiensis</i> human blood index (HBI) in Ethiopia. <b>Methods:</b> A comprehensive search of multiple electronic databases was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Study quality was assessed using criteria adopted from the Joanna Briggs Institute (JBI) appraisal checklist. Data were analyzed using Stata Version 17, employing a random-effects model to estimate the pooled HBI at 95% confidence interval (CI). Subgroup analysis and meta-regression were performed based on regions and mosquito collection methods. Heterogeneity was assessed using the <i>I</i> <sup>2</sup> test. <b>Results:</b> A total of 19 studies published from 1997 to 2023 were included, encompassing 12,794 blood-fed <i>An. arabiensis</i>. The meta-analysis revealed a pooled HBI of 37.18% (95% CI: 21.26-44.28). Subgroup analysis showed regional variation, with the highest HBI reported in Mixed Region 3 (covering Afar, Oromia, and the Amhara Regional States) at 64.02% (95% CI: 61.78-66.25), and the lowest in the Amhara Regional State at 7.53% (95% CI: -1.58-16.65). Temporal analysis indicated fluctuations over time, with the highest HBI reported in 2014 (70.62%, 95% CI: 68.72-72.46) and the lowest in 2021 (0%, 95% CI: 0.00-1.30). <b>Conclusion:</b> The present study found that <i>An. arabiensis</i> in Ethiopia exhibits a moderate preference for human blood, with a pooled HBI of 37.18%. However, significant variation exists across regions and over time. Continuous surveillance and further research are needed to explore the underlying factors influencing HBI and to guide evidence-based malaria prevention and control strategies.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"7891775"},"PeriodicalIF":2.5,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12414622/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145023525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-19eCollection Date: 2025-01-01DOI: 10.1155/jotm/8896234
Ettah Agnes Asonganyi, Elvis Asangbeng Tanue, Ginyu Innocentia Kwalar, Odette Dzemo Kibu, Moise Ondua, Maurice Marcel Sandeu, Patrick Jolly Ngono Ema, Denis Nkweteyim, Madeleine L Nyamsi, Peter L Achankeng, Christian Tchapga, Justine Ayuk, Gregory Eddie Halle-Ekane, Jude Dzevela Kong, Dickson Shey Nsagha
Background: Rapid digital responses to pandemics highlight advancements in healthcare, data sharing, and artificial intelligence (AI). While AI has driven progress in precision medicine, drug discovery, and vaccine development, its application to emerging and reemerging infectious diseases (ERIDs) remains underexplored, presenting critical challenges in addressing future health threats. Objectives: The study evaluated knowledge of ERIDs, AI, and Digital One Health (DOH) technologies, examined preparedness for their adoption in home healthcare, and identified factors influencing readiness to utilize these technologies in selected health districts of Cameroon. Methods: A cross-sectional study assessed the preparedness of communities in Buea, Limbe, Bonassama, and New-Bell Health Districts to adopt AI and DOH technologies from April to May 2024. Systematic random sampling included 33 communities, with data collected using face-to-face structured questionnaires. Analysis using SPSS Version 26 involved descriptive statistics and logistic regression, with statistical significance set at p < 0.05 and a 95% confidence interval to identify key associations. Results: Among 1625 participants, only 280 (17.2%) had good knowledge of ERIDs, with COVID-19 (68.8%) and cholera (94.5%) being the most recognized examples. Knowledge of AI and DOH technologies was poor, with only 166 (10.2%) demonstrating accurate understanding. Early disease detection emerged as a critical application of AI for ERID control. Preparedness to adopt AI and DOH technologies was reported by 941 (57.9%), with 64.5% comfortable with AI-generated interpretations and willing to use digital health tools during ERID outbreaks. Factors independently associated with preparedness included being a student (AOR = 2.678; 95% CI: 1.744-4.113; p < 0.001), good knowledge of AI and DOH (AOR = 7.141; 95% CI: 4.192-12.162; p < 0.001), and prior training on AI and digital health (AOR = 3.081; 95% CI: 2.272-4.179; p < 0.001). Conclusion: The study revealed insufficient knowledge of ERIDs, AI, and DOH but high preparedness to adopt these technologies for home care. Enhanced educational campaigns are recommended to improve community understanding and effective utilization of AI and DOH for controlling ERIDs.
背景:对流行病的快速数字响应突出了医疗保健、数据共享和人工智能(AI)方面的进步。虽然人工智能推动了精准医疗、药物发现和疫苗开发方面的进步,但其在新发和再发传染病(erid)方面的应用仍未得到充分探索,这对应对未来的健康威胁构成了严峻挑战。目的:本研究评估了erid、人工智能和数字健康(DOH)技术的知识,检查了在家庭医疗保健中采用这些技术的准备情况,并确定了影响喀麦隆选定卫生区利用这些技术的准备情况的因素。方法:一项横断面研究评估了2024年4月至5月Buea、Limbe、Bonassama和New-Bell卫生区社区采用AI和DOH技术的准备情况。系统随机抽样包括33个社区,采用面对面结构化问卷收集数据。使用SPSS Version 26进行分析,采用描述性统计和逻辑回归,统计显著性设置为p < 0.05, 95%置信区间确定关键关联。结果:在1625名参与者中,只有280人(17.2%)了解erid,其中COVID-19(68.8%)和霍乱(94.5%)是认知度最高的例子。对人工智能和DOH技术的认识较差,只有166人(10.2%)表现出准确的理解。早期疾病检测成为人工智能在ERID控制中的关键应用。941人(57.9%)报告准备采用人工智能和卫生保健技术,其中64.5%的人对人工智能生成的解释感到满意,并愿意在ERID爆发期间使用数字卫生工具。与准备相关的独立因素包括:学生身份(AOR = 2.678; 95% CI: 1.744-4.113; p < 0.001),对人工智能和DOH有良好的了解(AOR = 7.141; 95% CI: 4.192-12.162; p < 0.001),之前接受过人工智能和数字健康方面的培训(AOR = 3.081; 95% CI: 2.272-4.179; p < 0.001)。结论:研究显示对erid、人工智能和DOH的认识不足,但对采用这些技术进行家庭护理的准备程度很高。建议加强教育活动,以提高社区对人工智能和卫生部控制ERIDs的理解和有效利用。
{"title":"Preparedness of the Local Population for the Uptake of Artificial Intelligence and Digital One Health for Home Healthcare of Emerging and Reemerging Infectious Diseases in Southwest and Littoral Regions of Cameroon.","authors":"Ettah Agnes Asonganyi, Elvis Asangbeng Tanue, Ginyu Innocentia Kwalar, Odette Dzemo Kibu, Moise Ondua, Maurice Marcel Sandeu, Patrick Jolly Ngono Ema, Denis Nkweteyim, Madeleine L Nyamsi, Peter L Achankeng, Christian Tchapga, Justine Ayuk, Gregory Eddie Halle-Ekane, Jude Dzevela Kong, Dickson Shey Nsagha","doi":"10.1155/jotm/8896234","DOIUrl":"10.1155/jotm/8896234","url":null,"abstract":"<p><p><b>Background:</b> Rapid digital responses to pandemics highlight advancements in healthcare, data sharing, and artificial intelligence (AI). While AI has driven progress in precision medicine, drug discovery, and vaccine development, its application to emerging and reemerging infectious diseases (ERIDs) remains underexplored, presenting critical challenges in addressing future health threats. <b>Objectives:</b> The study evaluated knowledge of ERIDs, AI, and Digital One Health (DOH) technologies, examined preparedness for their adoption in home healthcare, and identified factors influencing readiness to utilize these technologies in selected health districts of Cameroon. <b>Methods:</b> A cross-sectional study assessed the preparedness of communities in Buea, Limbe, Bonassama, and New-Bell Health Districts to adopt AI and DOH technologies from April to May 2024. Systematic random sampling included 33 communities, with data collected using face-to-face structured questionnaires. Analysis using SPSS Version 26 involved descriptive statistics and logistic regression, with statistical significance set at <i>p</i> < 0.05 and a 95% confidence interval to identify key associations. <b>Results:</b> Among 1625 participants, only 280 (17.2%) had good knowledge of ERIDs, with COVID-19 (68.8%) and cholera (94.5%) being the most recognized examples. Knowledge of AI and DOH technologies was poor, with only 166 (10.2%) demonstrating accurate understanding. Early disease detection emerged as a critical application of AI for ERID control. Preparedness to adopt AI and DOH technologies was reported by 941 (57.9%), with 64.5% comfortable with AI-generated interpretations and willing to use digital health tools during ERID outbreaks. Factors independently associated with preparedness included being a student (AOR = 2.678; 95% CI: 1.744-4.113; <i>p</i> < 0.001), good knowledge of AI and DOH (AOR = 7.141; 95% CI: 4.192-12.162; <i>p</i> < 0.001), and prior training on AI and digital health (AOR = 3.081; 95% CI: 2.272-4.179; <i>p</i> < 0.001). <b>Conclusion:</b> The study revealed insufficient knowledge of ERIDs, AI, and DOH but high preparedness to adopt these technologies for home care. Enhanced educational campaigns are recommended to improve community understanding and effective utilization of AI and DOH for controlling ERIDs.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"8896234"},"PeriodicalIF":2.5,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12380506/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144959203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-19eCollection Date: 2025-01-01DOI: 10.1155/jotm/9731885
Claudia Munoz-Zanzi, Melissa Mueller, Natalia Coriano-Díaz, Ralph Rivera-Gutierrez, Christian Rivera-Cátala, Rachel Millán-Rodríguez, Rosa Cantres, Natalie M Piñeiro-Falcón, Daiana M Ríos-Núñez, Josean G Maldonado-Alfonzo, Renee Galloway, Luis J Santiago-Ramos, Amy Kircher, Deana Hallman, Lemuel Martinez, Robin Russel-Orama, Jarlath E Nally, Ilana J Schafer
Introduction: Leptospirosis is endemic to Puerto Rico, affecting people through seasonal increases and outbreaks. This report describes the diagnostic approach and clinical characteristics of leptospirosis cases identified through active undifferentiated acute febrile illness (UAFI) surveillance in Puerto Rico. Materials and Methods: From 2019 to 2021, active surveillance was conducted in four emergency departments (EDs), with standardized recruitment of patients aged ≥ 5 years, presenting with fever or a history of fever of unknown origin within the past two weeks. Additional cases were recruited from referrals of patients with positive leptospirosis diagnostic tests routinely ordered by clinicians. All enrolled patients were subject to a standardized diagnostic algorithm using PCR and serology to identify probable and confirmed leptospirosis cases. Patient data were collected from electronic medical records and interviews. Results: Leptospirosis was diagnosed in 4% of 406 ED-enrolled UAFI patients, eight confirmed and eight probable cases. Referrals resulted in the identification of 12 routinely detected cases (five confirmed and seven probable). Of the 28 cases, 71% were ≤ 7 days post onset, 71% were male, average age was 43 years old, and the most common presentations included lower back pain (82%), headache (75%), fatigue (71%), vomiting (71%), myalgia (71%), and calf pain (64%). Common clinical laboratory findings were elevated AST (78%), hyperglycemia (74%), thrombocytopenia (48%), proteinuria (62%), and hematuria (62%). Classification of four isolates identified L. interrogans serovar Icterohaemorrhagiae/Copenhageni (n = 2), L. borgpetersenii serovar Ballum/Guangdong, and L. kirschneri (no serovar match). All but one of the leptospirosis cases met the current Council of State and Territorial Epidemiologists' definition for clinical compatibility with leptospirosis. Hemorrhagic symptoms and acute kidney injury with jaundice were associated with being a leptospirosis case. Conclusions: These findings underscore the role of leptospirosis among febrile illnesses in Puerto Rico, the need for increased awareness to optimize diagnosis and treatment, and further research to improve prevention and intervention strategies.
{"title":"Diagnosis and Clinical Description of Leptospirosis Cases Identified Through Hospital-Based Active Surveillance in Puerto Rico, 2019-2021.","authors":"Claudia Munoz-Zanzi, Melissa Mueller, Natalia Coriano-Díaz, Ralph Rivera-Gutierrez, Christian Rivera-Cátala, Rachel Millán-Rodríguez, Rosa Cantres, Natalie M Piñeiro-Falcón, Daiana M Ríos-Núñez, Josean G Maldonado-Alfonzo, Renee Galloway, Luis J Santiago-Ramos, Amy Kircher, Deana Hallman, Lemuel Martinez, Robin Russel-Orama, Jarlath E Nally, Ilana J Schafer","doi":"10.1155/jotm/9731885","DOIUrl":"10.1155/jotm/9731885","url":null,"abstract":"<p><p><b>Introduction:</b> Leptospirosis is endemic to Puerto Rico, affecting people through seasonal increases and outbreaks. This report describes the diagnostic approach and clinical characteristics of leptospirosis cases identified through active undifferentiated acute febrile illness (UAFI) surveillance in Puerto Rico. <b>Materials and Methods:</b> From 2019 to 2021, active surveillance was conducted in four emergency departments (EDs), with standardized recruitment of patients aged ≥ 5 years, presenting with fever or a history of fever of unknown origin within the past two weeks. Additional cases were recruited from referrals of patients with positive leptospirosis diagnostic tests routinely ordered by clinicians. All enrolled patients were subject to a standardized diagnostic algorithm using PCR and serology to identify probable and confirmed leptospirosis cases. Patient data were collected from electronic medical records and interviews. <b>Results:</b> Leptospirosis was diagnosed in 4% of 406 ED-enrolled UAFI patients, eight confirmed and eight probable cases. Referrals resulted in the identification of 12 routinely detected cases (five confirmed and seven probable). Of the 28 cases, 71% were ≤ 7 days post onset, 71% were male, average age was 43 years old, and the most common presentations included lower back pain (82%), headache (75%), fatigue (71%), vomiting (71%), myalgia (71%), and calf pain (64%). Common clinical laboratory findings were elevated AST (78%), hyperglycemia (74%), thrombocytopenia (48%), proteinuria (62%), and hematuria (62%). Classification of four isolates identified <i>L. interrogans</i> serovar Icterohaemorrhagiae/Copenhageni (<i>n</i> = 2), <i>L. borgpetersenii</i> serovar Ballum/Guangdong, and <i>L. kirschneri</i> (no serovar match). All but one of the leptospirosis cases met the current Council of State and Territorial Epidemiologists' definition for clinical compatibility with leptospirosis. Hemorrhagic symptoms and acute kidney injury with jaundice were associated with being a leptospirosis case. <b>Conclusions:</b> These findings underscore the role of leptospirosis among febrile illnesses in Puerto Rico, the need for increased awareness to optimize diagnosis and treatment, and further research to improve prevention and intervention strategies.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"9731885"},"PeriodicalIF":2.5,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12381401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144959280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}